News and Announcements
Innovative SaaS Platform miiGroup Announces 20% WoW Growth and a Closing Pre-Series A
- Published March 01, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
miiGroup CEO and Founder, Jason Knight, recently provided the latest update on the company’s current activities as well as plans for the future announced. In his update, Mr Knight shared their strong goals for 2017, announced current week on week growth of 20%, and more.
KEY TAKEAWAYS:
- 20% week on week growth
- Shane Preston has been added to the advisory board bringing his experience in strategy and commercialisation to the miiGroup board.
- iCompLii and miiFile are now “truly built and relaunched”.
- MiningLink’s Focus has been returned to the marketing tool it was designed for, allowing miigGroup products to be promoted to the 1.1 million people it reaches per week on average.
- Pre-Series A closing soon
miiGroup has had a strong start to the year with the company sustaining more than 20% week on week growth.
The company has added Shane Preston to their advisory board bringing his experience in strategy & commercialisation to the board, which is in line with mmGroup’s strategy of creating a more professional board to further strengthen the company through-out 2017.
miiGroup’s products iCompLii and miiFile have now been built and relaunched. With new signups rolling in and client discussions restarted, the company has further focused their operating boundaries to fit back within the model of portable verifiable digital identities and the ability to leverage that data as a single source of truth, through subscription based access.
As such, MiningLink’s focus has been returned to the marketing tool it was designed for, allowing miiGroup products to be promoted to the 1.1 million people it reaches on an average week.
With only a limited amount of shares available, the Pre-series A round is expected to close soon.
Company Updates
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
Backed By Leading Investment Groups and Family Offices
